Supernus Pharmaceuticals, Inc.

MetLife Investment Management, LLC SUPN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

303,716

Value ($000)

15,095

Weight

0.1%

2018 Q3 - 2025 Q4 (30 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	15,095	0.1%	303,716	12/31/2025
2025 Q3	11/13/2025	1,540	0.0%	32,228	9/30/2025
2025 Q2	8/13/2025	1,016	0.0%	32,228	6/30/2025
2025 Q1	5/14/2025	993	0.0%	30,333	3/31/2025
2024 Q4	2/13/2025	1,115	0.0%	30,822	12/31/2024
2024 Q3	11/13/2024	918	0.0%	29,428	9/30/2024
2024 Q2	8/13/2024	787	0.0%	29,428	6/30/2024
2024 Q1	5/14/2024	887	0.0%	26,005	3/31/2024
2023 Q4	4/22/2024	753	0.0%	26,005	12/31/2023
2023 Q3	5/9/2024	717	0.0%	26,005	9/30/2023
2023 Q2	4/29/2024	782	0.0%	26,005	6/30/2023
2023 Q1	5/9/2024	942	0.0%	26,005	3/31/2023
2022 Q4	5/10/2024	928	0.0%	26,005	12/31/2022
2022 Q3	5/10/2024	909	0.0%	26,839	9/30/2022
2022 Q2	5/10/2024	806	0.0%	27,869	6/30/2022
2022 Q1	5/10/2024	901	0.0%	27,869	3/31/2022
2021 Q4	5/17/2024	525	0.0%	17,997	12/31/2021
2021 Q3	5/17/2024	480	0.0%	17,997	9/30/2021
2021 Q2	5/17/2024	554	0.0%	17,997	6/30/2021
2021 Q1	5/17/2024	589	0.0%	22,494	3/31/2021
2020 Q4	5/24/2024	566	0.0%	22,494	12/31/2020
2020 Q3	5/24/2024	469	0.0%	22,494	9/30/2020
2020 Q2	5/24/2024	534	0.0%	22,494	6/30/2020
2020 Q1	7/12/2023	405	0.0%	22,494	3/31/2020
2019 Q4	7/12/2023	534	0.0%	22,494	12/31/2019
2019 Q3	7/12/2023	618	0.0%	22,494	9/30/2019
2019 Q2	7/12/2023	744	0.0%	22,494	6/30/2019
2019 Q1	7/13/2023	788	0.0%	22,494	3/31/2019
2018 Q4	7/13/2023	747	0.0%	22,494	12/31/2018
2018 Q3	7/13/2023	1,133	0.0%	22,494	9/30/2018